“clinical-trials” Archives

in
Entry Author Date Location
Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials 08/11/20 National
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare 08/07/20 National
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage 08/04/20 San Francisco
AbbVie Walks From Voyager R&D Pact Spanning Alzheimer’s, Parkinson’s 08/04/20 Boston
MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T 08/03/20 Europe
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients 07/30/20 Boston
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
AstraZeneca to Pay $1B to Team Up With Daiichi Sankyo Again in Cancer 07/27/20 Europe
Clinical Trial Diversity Isn’t Just a Moral Issue–It’s a Scientific Imperative 07/27/20 National
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding 07/21/20 National
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
MeiraGTx, J&J See Phase 3 Test Ahead for Vision Loss Gene Therapy 07/17/20 New York
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Mallinckrodt’s Kidney Failure Drug Narrowly Wins Backing of FDA Panel 07/16/20 Europe
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Page 3 of 56 « previous page · next page »